In Vitro Investigation of Thiol-Functionalized Cellulose Nanofibrils as a Chronic Wound Environment Modulator.

antioxidant properties cysteine nanocellulose proteases reactive oxygen species wound healing

Journal

Polymers
ISSN: 2073-4360
Titre abrégé: Polymers (Basel)
Pays: Switzerland
ID NLM: 101545357

Informations de publication

Date de publication:
13 Jan 2021
Historique:
received: 08 12 2020
revised: 09 01 2021
accepted: 10 01 2021
entrez: 16 1 2021
pubmed: 17 1 2021
medline: 17 1 2021
Statut: epublish

Résumé

There is currently a huge need for new, improved therapeutic approaches for the treatment of chronic wounds. One promising strategy is to develop wound dressings capable of modulating the chronic wound environment (e.g., by controlling the high levels of reactive oxygen species (ROS) and proteases). Here, we selected the thiol-containing amino acid cysteine to endow wood-derived cellulose nanofibrils (CNF) with bioactivity toward the modulation of ROS levels and protease activity. Cysteine was covalently incorporated into CNF and the functionalized material, herein referred as cys-CNF, was characterized in terms of chemical structure, degree of substitution, radical scavenging capacity, and inhibition of protease activity. The stability of the thiol groups was evaluated over time, and an in vitro cytotoxicity study with human dermal fibroblasts was performed to evaluate the safety profile of cys-CNF. Results showed that cys-CNF was able to efficiently control the activity of the metalloprotease collagenase and to inhibit the free radical DPPH (1,1-Diphenyl-2-picrylhydrazyl radical), activities that were correlated with the presence of free thiol groups on the nanofibers. The stability study showed that the reactivity of the thiol groups challenged the bioactivity over time. Nevertheless, preparing the material as an aerogel and storing it in an inert atmosphere were shown to be valid approaches to increase the stability of the thiol groups in cys-CNF. No signs of toxicity were observed on the dermal fibroblasts when exposed to cys-CNF (concentration range 0.1-0.5 mg/mL). The present work highlights cys-CNF as a promising novel material for the development of bioactive wound dressings for the treatment of chronic wounds.

Identifiants

pubmed: 33451171
pii: polym13020249
doi: 10.3390/polym13020249
pmc: PMC7828681
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Swedish Research Council
ID : 2018-04613
Organisme : Olle Engkvists Stiftelse
ID : 191-419

Références

Biomolecules. 2014 Apr 17;4(2):419-34
pubmed: 24970223
Sci Transl Med. 2014 Dec 3;6(265):265sr6
pubmed: 25473038
Int Wound J. 2017 Feb;14(1):89-96
pubmed: 26688157
J Control Release. 2016 Dec 28;244(Pt B):292-301
pubmed: 27491880
Physiol Genomics. 2016 Dec 1;48(12):889-896
pubmed: 27764766
Carbohydr Polym. 2016 Oct 5;150:65-73
pubmed: 27312614
ACS Omega. 2019 Dec 10;4(26):22008-22020
pubmed: 31891081
Sci Rep. 2017 Dec 21;7(1):18031
pubmed: 29269741
Langmuir. 2019 Apr 2;35(13):4471-4480
pubmed: 30793909
Nanomaterials (Basel). 2018 Jul 20;8(7):
pubmed: 30036970
Nanomaterials (Basel). 2019 Jan 29;9(2):
pubmed: 30699947
Part Fibre Toxicol. 2017 Jan 10;14(1):1
pubmed: 28069023
Nanomaterials (Basel). 2020 Jun 12;10(6):
pubmed: 32545575
Int J Biochem Cell Biol. 2002 Dec;34(12):1544-56
pubmed: 12379277
ACS Cent Sci. 2017 Mar 22;3(3):163-175
pubmed: 28386594
Carbohydr Polym. 2018 Feb 1;181:345-350
pubmed: 29253982
Carbohydr Polym. 2012 Oct 1;90(2):735-64
pubmed: 22839998
Am J Surg. 1998 Aug;176(2A Suppl):26S-38S
pubmed: 9777970
Biochim Biophys Acta. 2010 Jan;1803(1):72-94
pubmed: 19712708
Macromol Biosci. 2017 Nov;17(11):
pubmed: 28941135
J Nanobiotechnology. 2016 Dec 1;14(1):78
pubmed: 27903280
Carbohydr Polym. 2017 Oct 15;174:299-308
pubmed: 28821071
Front Biosci. 2004 Jan 01;9:283-9
pubmed: 14766366
Biomaterials. 2003 Apr;24(9):1549-57
pubmed: 12559815
Adv Wound Care (New Rochelle). 2020 Apr 1;9(4):199-210
pubmed: 32117583
Angew Chem Int Ed Engl. 2011 Jun 6;50(24):5438-66
pubmed: 21598362
Carbohydr Polym. 2019 Feb 15;206:187-197
pubmed: 30553312
BMC Chem. 2019 Mar 23;13(1):33
pubmed: 31384781
Adv Wound Care (New Rochelle). 2013 Oct;2(8):438-447
pubmed: 24688830
Spectrochim Acta A Mol Biomol Spectrosc. 2020 Jun 5;233:118158
pubmed: 32143172
Trials. 2020 Jun 8;21(1):505
pubmed: 32513260
Biomaterials. 2002 May;23(10):2255-64
pubmed: 11962667
Adv Healthc Mater. 2020 Mar;9(5):e1901502
pubmed: 31977162

Auteurs

Anna Blasi-Romero (A)

Nanotechnology and Functional Materials, Department of Material Science and Engineering, Uppsala University, Box 35, 75103 Uppsala, Sweden.

Carlos Palo-Nieto (C)

Nanotechnology and Functional Materials, Department of Material Science and Engineering, Uppsala University, Box 35, 75103 Uppsala, Sweden.

Corine Sandström (C)

Department of Molecular Sciences, Swedish University of Agricultural Sciences, Box 7015, 75007 Uppsala, Sweden.

Jonas Lindh (J)

Nanotechnology and Functional Materials, Department of Material Science and Engineering, Uppsala University, Box 35, 75103 Uppsala, Sweden.

Maria Strømme (M)

Nanotechnology and Functional Materials, Department of Material Science and Engineering, Uppsala University, Box 35, 75103 Uppsala, Sweden.

Natalia Ferraz (N)

Nanotechnology and Functional Materials, Department of Material Science and Engineering, Uppsala University, Box 35, 75103 Uppsala, Sweden.

Classifications MeSH